| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $332K | +5.15K | +74.65% | $64.38 | 12K | May 1, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$1.03M | -5.15K | -42.74% | $200.04 | 6.9K | May 1, 2023 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $113K | +1.99K | +28.84% | $56.77 | 8.89K | May 1, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$398K | -1.99K | -22.39% | $200.12 | 6.9K | May 1, 2023 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Sale | -$59K | -295 | -4.28% | $200.06 | 6.6K | May 1, 2023 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Sale | -$978K | -4.89K | -21.21% | $200.06 | 18.2K | May 1, 2023 | by Trust | F2, F6 |
| transaction | SGEN | Common Stock | Options Exercise | $122K | +1.89K | +28.59% | $64.38 | 8.49K | May 2, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$378K | -1.89K | -22.23% | $200.05 | 6.6K | May 2, 2023 | Direct | F1, F2, F7 |
| transaction | SGEN | Common Stock | Options Exercise | $508K | +3.17K | +48.02% | $160.33 | 9.78K | May 2, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$634K | -3.17K | -32.44% | $200.05 | 6.6K | May 2, 2023 | Direct | F1, F2, F8 |
| transaction | SGEN | Common Stock | Options Exercise | $511K | +3.46K | +52.42% | $147.50 | 10.1K | May 2, 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | -$693K | -3.46K | -34.39% | $200.10 | 6.6K | May 2, 2023 | Direct | F1, F2, F9 |
| transaction | SGEN | Common Stock | Sale | -$70.2K | -351 | -5.31% | $200.07 | 6.25K | May 2, 2023 | Direct | F1, F2, F10 |
| transaction | SGEN | Common Stock | Sale | -$1.17M | -5.84K | -32.11% | $200.07 | 12.3K | May 2, 2023 | by Trust | F2, F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.99K | -100% | $0.00* | 0 | May 1, 2023 | Common Stock | 1.99K | $56.77 | Direct | F11 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -5.15K | -73.17% | $0.00 | 1.89K | May 1, 2023 | Common Stock | 5.15K | $64.38 | Direct | F12 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.89K | -100% | $0.00* | 0 | May 2, 2023 | Common Stock | 1.89K | $64.38 | Direct | F12 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.17K | -100% | $0.00* | 0 | May 2, 2023 | Common Stock | 3.17K | $160.33 | Direct | F13 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3.46K | -100% | $0.00* | 0 | May 2, 2023 | Common Stock | 3.46K | $147.50 | Direct | F14 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.03 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F8 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F9 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.05 to $200.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F10 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.16 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F11 | Options vested in full on 5/18/19. |
| F12 | Options vested in full on 5/20/20. |
| F13 | Options vested in full on 5/15/21. |
| F14 | Options vested in full on 5/14/22. |